NEW YORK (GenomeWeb) – UK-based Genedrive announced today that it has signed a conditional agreement with a firm called Epistem 2 to sell its contract research and pharmacogenomics divisions for a cash consideration of up to £1.9 million ($2.6 million), as part of a strategy to focus entirely on the molecular diagnostics market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: MYRF variant linked to congenital diaphragmatic hernia, analysis of the "dragon's blood" red resin produced by traditional medicine plants, and more.

CNBC reports that half of academic researchers leave after about five years.

Researchers have used genetic analysis to confirm a new type of salamander, the New York Times reports.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.